Mar 23, 2022 7:00am EDT XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
Mar 14, 2022 7:00am EDT XORTX Therapeutics Announces Submission of Clinical Trial Application to Conduct Bridging Pharmacokinetics Study